23.12.2015 • News • Elaine Burridge • Mergers & Acquisitions (M&A) • Brenntag

Brenntag Buys German Specialty Polymers Distributor

German chemical distributor Brenntag has signed an agreement to purchase Leis Polytechnik for €15.9 million. The company specializes in the development, production and distribution of high-performance polymer compounds.

The acquisition expands Brenntag’s engineering and high-performance polymers portfolio to include compounding, which the distributor notes is a fast-growing business.

Anthony Gerace, Brenntag’s managing director for Mergers & Acquisitions, said Leis is a perfect supplement to its market footprint and portfolio of specialty polymers. The company supplies around 700 products for various applications in the automotive, electronics, medical technology, packaging, and building and construction industries.

The acquired business is expected to generate sales of about €11.3 million in the 2016 financial year. The transaction is due to close in the coming weeks.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Top-Feature

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.